Staying one step ahead of your rivals

Article 1 of 3: The fixed income landscape is in flux. In this series of three blogs, I’ll explore the important trends we see dominating the fixed income space in the year ahead: technology, liquidity and operational efficiency. After years of resisting innovation and the adoption of technology in the same way as other asset…

Trials and Triumphs of Gene Editing: A Compendium

THE COWEN INSIGHT While offering curative potential, much remains to be known about the long-term clinical activity and safety of gene editing therapies. We expect answers to these complex questions will continue to be a key investor focus as programs advance. While the clinical and regulatory progress of gene therapies may inform the road ahead…

Help Wanted! Talent Acquisition Tech is an Emerging Public Market

THE COWEN INSIGHT Talent acquisition tech represents the next major investable universe within human capital management with staying power in the public markets as a separate class of companies. Talent acquisition has become a top priority with growing acknowledgement that talent represents organizations most significant asset. The pandemic has introduced further challenges to already tight…

Acelyrin, Inc. Closes $250 Million Series B Financing and Announces Licensing of Izokibep, a Late-Stage IL-17A Inhibitor to Treat Inflammatory Diseases

Series B led by Matrix Capital Management, Surveyor-Citadel Capital, and Westlake Village BioPartners Currently enrolling izokibep in a pivotal trial in uveitis and a Phase 2b trial in axial spondyloarthritis; activities underway for a Phase 2b trial in hidradenitis suppurativa LOS ANGELES, CA., NOVEMBER 16, 2021 – ACELYRIN, INC., an innovative biopharma company that identifies,

Private Equity Is Ready to Take MSP Consolidation to the Next Level

By Mike McGill and Kevin Jolley The outlook for managed service providers (MSPs) remains positive, as increasing complexity and security concerns – driven by the work-from-anywhere environment and high-profile hacking incidents – have moved IT management from being a cost center to a core strategic priority for the C-suite. A key driver of the growth…

Commission Management

Provided by Westminster Research Associates LLC, a leading provider of investment research and commission management solutions Specializing in commission sharing arrangements (CSA) and research payment accounts (RPA) Monitoring, control, record-keeping, reporting of research funding and payments…

Capital Introduction

Helps clients to secure capital and to grow Experienced global capital intro team with differentiated network across Europe, Asia US Facilitates highly targeted introductions with a network of 1,000+ investors targeting emerging and mid-sized funds Focuses on the investment merits and aligning investment strategies, operational capabilities and performance track record…

Tyler Van Buren

Mr. Van Buren originally joined Cowen in the beginning of 2013 as an associate on the biopharma research team. He grew into a covering analyst and rejoined Cowen in 2021 after a 3+ year stint at Piper Sandler. Mr. Van Buren's responsibility as a senior biotech equity research analyst is to provide analysis on large-, mid-, and small-cap biotechnology stocks for institutional investors and support the investment banking group by providing due diligence.

From the Desk: The art of focusing on the full trade lifecycle

When people talk about the advantages of outsourcing the trading desk, they often think solely about execution and whether an asset manager can achieve a desired trading goal. But what happens before and after a transaction can be just as important. From pre-trade analytics through to post-trade transaction cost analysis (TCA) reports, Cowen understands that…

Daniel Brennan

At Cowen, Dan is responsible for providing research coverage on a diverse group of companies across the Life Science Diagnostics Tools industry. This includes identifying key investment debates, building financial models, generating research reports, including Ahead of the Curve deep dive analysis, making stock recommendations and engaging with clients and Cowen representatives. Daniel Brennan…

Tobias Levedag

Tobias Levedag is Managing Director of Investment Banking at Cowen Europe. Based in Munich, he has over 13 years of experience providing M&A advice and fundraising services to companies and shareholders in the natural resources, consumer and healthcare industries.

Load More